SynthesisClinical therapeutics2012

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Iris Navarro-Millán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.